These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 335498)

  • 21. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC; Ortíz Feijoo J; Otero Cagide F
    Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
    Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
    Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY
    Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 27. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
    Gragnoli G; Puccetti F; Tanganelli I; Favilli R; Nami R
    Minerva Med; 1975 Apr; 66(30):1412-6. PubMed ID: 1143685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of a spironolactone and althiazide combination (aldactacine) in the treatment of benign essential hypertension.
    Mngola EN
    J Int Med Res; 1980; 8(3):199-204. PubMed ID: 6993252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive responses to spironolactone in normal renin hypertension.
    Ogilvie RI; Piafsky KM; Ruedy J
    Clin Pharmacol Ther; 1978 Nov; 24(5):525-30. PubMed ID: 699476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study.
    Scherstén B; Thulin T; Kuylenstierna J; Engström M; Karlberg BE; Tolagen K; Nordlander S; Nilsson G
    Hypertension; 1980; 2(5):672-9. PubMed ID: 6998872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerance of spironolactone in essential hypertension.
    Jeunemaitre X; Chatellier G; Kreft-Jais C; Charru A; DeVries C; Plouin PF; Corvol P; Menard J
    Am J Cardiol; 1987 Oct; 60(10):820-5. PubMed ID: 3661395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral action of spironolactone: plethysmographic studies.
    Clement DL
    Am J Cardiol; 1990 Jun; 65(23):12K-13K. PubMed ID: 2191584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spironolactones in the treatment of essential arterial hypertension: analysis of the results obtained in 306 patients].
    Cagli V; Marquez JR; Sanguigni D
    Boll Soc Ital Cardiol; 1978; 23(10):1749-56. PubMed ID: 261838
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma potassium in hypertensive Africans on frusemide.
    Adu D; Nkrumah KN; Larbi EB; Pobee JO; Adjei DO
    J Int Med Res; 1978; 6(3):207-12. PubMed ID: 648737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of anti-aldosterone agents and hypotensive diuretics in essential hypertension by a double blind test].
    Shimizu N; Miyashita H; Koide K; Inoue N; Ogasawara M
    Horumon To Rinsho; 1977 Feb; 25(2):167-74. PubMed ID: 322896
    [No Abstract]   [Full Text] [Related]  

  • 37. Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.
    Langote A; Hiremath S; Ruzicka M; McCormick BB
    PLoS One; 2017; 12(11):e0187269. PubMed ID: 29125879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of single and divided daily dose spironolactone in the control of hypertension.
    Bell GM; Fananapazir L; Anderton JL
    Br J Clin Pharmacol; 1981 Oct; 12(4):585-8. PubMed ID: 7295494
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of a single-dose and twice-a-day spironolactone therapy in mild hypertension.
    Ludbrook A; Dynon M; Mendelsohn FA; Louis WJ
    Med J Aust; 1980 Feb; 1(3):124-5. PubMed ID: 6990208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypertension with spironolactone. Double-blind study.
    Wolf RL; Mendlowitz M; Roboz J; Styan GP; Kornfeld P; Weigl A
    JAMA; 1966 Dec; 198(11):1143-9. PubMed ID: 5332539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.